Related Experiment Videos
Interleukin 12 and innate molecules for enhanced mucosal immunity
P N Boyaka1, J W Lillard, J McGhee
1The Immunobiology Vaccine Center, The University of Alabama at Birmingham, 35294-2170, USA.
Immunologic Research
|March 31, 2000
Summary
Interleukin-12 (IL-12) and lymphotactin effectively promote mucosal secretory IgA (S-IgA) antibody responses. These findings offer new strategies for developing targeted mucosal vaccines by modulating innate immunity molecules.
Area of Science:
- Immunology
- Vaccinology
Background:
- Understanding mucosal immunity is crucial for developing effective vaccines.
- Cytokines and innate immunity molecules influence T helper (Th) cell development and immune responses.
Purpose of the Study:
- To investigate the impact of innate immunity molecules, specifically IL-6, IL-12, human neutrophil peptides (HNPs), and lymphotactin, on mucosal and systemic immune responses to protein antigens.
- To determine the potential of these molecules in enhancing targeted mucosal vaccine efficacy.
Main Methods:
- Mice were nasally administered protein antigens with either IL-6, IL-12, HNPs, or lymphotactin.
- Antigen-specific antibody (Ab) responses (serum and mucosal IgA) and Th cell responses (cytokine secretion) were analyzed.
Main Results:
- IL-12 and lymphotactin enhanced both mucosal IgA and systemic antibody responses.
- IL-12 and lymphotactin modulated Th cell responses, with IL-12 inducing higher IFN-gamma and IL-6 secretion.
- HNPs enhanced systemic immunity but failed to significantly boost mucosal immune responses.
Conclusions:
- IL-12 and lymphotactin are potent inducers of mucosal S-IgA responses.
- These molecules provide promising avenues for designing safe and targeted mucosal vaccines.